• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec31
Distribution Plan(EST)

Cash dividend 0.3811 USD

Dec12
Distribution Plan(EST)

Cash dividend 0.3811 USD

Distribution Plan(EST)

Cash dividend 0.3811 USD

View More

Event Tracking

Dec10
Stoke Therapeutics Inc. Director Sells Company Common Stock
21:24
Rigel Pharmaceuticals Updates R289 Phase 1b Trial Data
21:07
Dec7
R289 Achieves 40% Success Rate in Treating Older Patients with Low-Risk Myelodysplastic Syndromes
14:53
Rigel Pharmaceuticals Announces Encouraging Results for R289 in Low-Risk MDS Patients
14:30
Dec5
Stoke Therapeutics and Biogen Show Positive Data for Dravet Syndrome Drug
14:00
Dec2
Ameresco Completes Solar Photovoltaic Project for Orange Unified School District
13:05